# 60 DEGREES PHARMACEUTICALS, INC. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:12add3a6-8322-418a-86c4-ae142e1f555f | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/60-degrees-pharmaceuticals-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 25 | | Claims under review | 1 | | Evidence records | 6 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-15T04:48:17.554305+00:00 | | Last reviewed | 2026-10-15T04:48:17.554305+00:00 | ## Identity - Legal name: 60 DEGREES PHARMACEUTICALS, INC. - Display name: 60 DEGREES PHARMACEUTICALS, INC. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-16T01:55:07.023584+00:00 | | Completeness | 0.409 | | Record Quality | 0.829 | | Directors | 5 | | Committees | 6 | | Governance events | 14 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Charles Allen: Director. Status: current. Independent: true. Since: 2023-01-01. Committees: Audit (chair); Audit · Chair; Compensation; Nominating and Governance (member); Compensation (member); Nominating and Governance (member). claim_id=alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:5 - Cheryl Xu: Director. Status: current. Independent: false. Since: 2023-01-01. claim_id=alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:6 - Geoffrey Dow: Director. Status: current. Independent: false. Since: 2022-01-01. claim_id=alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:7 - Paul Field: Director. Status: current. Independent: true. Since: 2023-01-01. Committees: Audit (member); Audit; Compensation · Chair; Nominating and Governance (member); Compensation (chair); Nominating and Governance (member). claim_id=alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:8 - Stephen Toovey: Director. Status: current. Independent: true. Since: 2023-01-01. Committees: Audit (member); Audit; Compensation; Nominating and Governance · Chair (member); Compensation (member); Nominating and Governance (chair). claim_id=alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:9 ## Committees - Audit (audit). Chair: Charles Allen. Members: Charles Allen (chair, current); Paul Field (member, current); Stephen Toovey (member, current). committee_id=alpha:committee:60-degrees-pharmaceuticals-inc:audit - Audit · Chair; Compensation; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Charles Allen (member, current). committee_id=alpha:committee:60-degrees-pharmaceuticals-inc:audit-chair-compensation-nominating-and-governance - Audit; Compensation · Chair; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Paul Field (member, current). committee_id=alpha:committee:60-degrees-pharmaceuticals-inc:audit-compensation-chair-nominating-and-governance - Audit; Compensation; Nominating and Governance · Chair (audit). Chair: NOT_PUBLISHED. Members: Stephen Toovey (member, current). committee_id=alpha:committee:60-degrees-pharmaceuticals-inc:audit-compensation-nominating-and-governance-chair - Compensation (compensation). Chair: Paul Field. Members: Paul Field (chair, current); Charles Allen (member, current); Stephen Toovey (member, current). committee_id=alpha:committee:60-degrees-pharmaceuticals-inc:compensation - Nominating and Governance (nominating_governance). Chair: Stephen Toovey. Members: Stephen Toovey (chair, current); Charles Allen (member, current); Paul Field (member, current). committee_id=alpha:committee:60-degrees-pharmaceuticals-inc:nominating-and-governance ## Executive leadership - Geoffrey Dow: Chief Executive Officer, President and Director [CEO]. Status: current. claim_id=alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:10 - Kristen Landon: Chief Commercial Officer. Status: current. claim_id=alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:11 - Theodore C. Miller: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:12 ## Governance events - CEO_CHANGED: Geoffrey Dow executive of 60 DEGREES PHARMACEUTICALS, INC., effective 2026-03-30. Effective: 2026-03-30. Detected: 2026-10-15T04:48:17.554305+00:00. event_id=alpha:event:transition:1u1vdt41mbyplu - EXECUTIVE_APPOINTED: Kristen Landon executive of 60 DEGREES PHARMACEUTICALS, INC., effective 2026-03-30. Effective: 2026-03-30. Detected: 2026-10-15T04:48:17.554305+00:00. event_id=alpha:event:transition:9t9ovnio42x9 - CFO_CHANGED: Theodore C. Miller executive of 60 DEGREES PHARMACEUTICALS, INC., effective 2026-03-30. Effective: 2026-03-30. Detected: 2026-10-15T04:48:17.554305+00:00. event_id=alpha:event:transition:67a49x15zfuxr - DIRECTOR_APPOINTED: Charles Allen seat on 60 DEGREES PHARMACEUTICALS, INC., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-15T04:48:17.554305+00:00. event_id=alpha:event:transition:k4ty216ynjpu - DIRECTOR_APPOINTED: Cheryl Xu seat on 60 DEGREES PHARMACEUTICALS, INC., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-15T04:48:17.554305+00:00. event_id=alpha:event:transition:1ne64zbxwd9p9 - DIRECTOR_APPOINTED: Paul Field seat on 60 DEGREES PHARMACEUTICALS, INC., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-15T04:48:17.554305+00:00. event_id=alpha:event:transition:4x6v0t1t4sv6r - DIRECTOR_APPOINTED: Stephen Toovey seat on 60 DEGREES PHARMACEUTICALS, INC., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-15T04:48:17.554305+00:00. event_id=alpha:event:transition:fwyeei1izv3eu - COMMITTEE_CREATED: Audit · Chair; Compensation; Nominating and Governance committee of 60 DEGREES PHARMACEUTICALS, INC., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-15T04:48:17.554305+00:00. event_id=alpha:event:transition:ugzpjw121j286 - COMMITTEE_MEMBER_ADDED: Charles Allen member of Audit · Chair; Compensation; Nominating and Governance, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-15T04:48:17.554305+00:00. event_id=alpha:event:transition:1fg357i16m5p0a - COMMITTEE_CREATED: Audit; Compensation · Chair; Nominating and Governance committee of 60 DEGREES PHARMACEUTICALS, INC., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-15T04:48:17.554305+00:00. event_id=alpha:event:transition:908ued4yrad7 - COMMITTEE_MEMBER_ADDED: Paul Field member of Audit; Compensation · Chair; Nominating and Governance, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-15T04:48:17.554305+00:00. event_id=alpha:event:transition:q29vjh1v9wbub - COMMITTEE_CREATED: Audit; Compensation; Nominating and Governance · Chair committee of 60 DEGREES PHARMACEUTICALS, INC., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-15T04:48:17.554305+00:00. event_id=alpha:event:transition:1odm4881ss8c2a - COMMITTEE_MEMBER_ADDED: Stephen Toovey member of Audit; Compensation; Nominating and Governance · Chair, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-15T04:48:17.554305+00:00. event_id=alpha:event:transition:30qlm45aukh6 - DIRECTOR_APPOINTED: Geoffrey Dow seat on 60 DEGREES PHARMACEUTICALS, INC., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-15T04:48:17.554305+00:00. event_id=alpha:event:transition:p3j4b1bgwqx5 ## Scoped resources - `alpha://company/60-degrees-pharmaceuticals-inc` (contract): https://registry.alpha.ac/api/public/companies/60-degrees-pharmaceuticals-inc?format=record - `alpha://company/60-degrees-pharmaceuticals-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/60-degrees-pharmaceuticals-inc?format=record§ion=identity - `alpha://company/60-degrees-pharmaceuticals-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/60-degrees-pharmaceuticals-inc?format=record§ion=corporate-structure - `alpha://company/60-degrees-pharmaceuticals-inc/board` (contract): https://registry.alpha.ac/api/public/companies/60-degrees-pharmaceuticals-inc?format=record§ion=board - `alpha://company/60-degrees-pharmaceuticals-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/60-degrees-pharmaceuticals-inc?format=record§ion=committees - `alpha://company/60-degrees-pharmaceuticals-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/60-degrees-pharmaceuticals-inc?format=record§ion=leadership - `alpha://company/60-degrees-pharmaceuticals-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/60-degrees-pharmaceuticals-inc?format=record§ion=ownership - `alpha://company/60-degrees-pharmaceuticals-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/60-degrees-pharmaceuticals-inc?format=record§ion=financials - `alpha://company/60-degrees-pharmaceuticals-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/60-degrees-pharmaceuticals-inc?format=record§ion=capital-structure - `alpha://company/60-degrees-pharmaceuticals-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/60-degrees-pharmaceuticals-inc?format=record§ion=compensation - `alpha://company/60-degrees-pharmaceuticals-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/60-degrees-pharmaceuticals-inc?format=record§ion=governance - `alpha://company/60-degrees-pharmaceuticals-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/60-degrees-pharmaceuticals-inc?format=record§ion=shareholder-governance - `alpha://company/60-degrees-pharmaceuticals-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/60-degrees-pharmaceuticals-inc?format=record§ion=audit - `alpha://company/60-degrees-pharmaceuticals-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/60-degrees-pharmaceuticals-inc?format=record§ion=legal - `alpha://company/60-degrees-pharmaceuticals-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/60-degrees-pharmaceuticals-inc?format=record§ion=risk - `alpha://company/60-degrees-pharmaceuticals-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/60-degrees-pharmaceuticals-inc?format=record§ion=cyber - `alpha://company/60-degrees-pharmaceuticals-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/60-degrees-pharmaceuticals-inc?format=record§ion=ai-governance - `alpha://company/60-degrees-pharmaceuticals-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/60-degrees-pharmaceuticals-inc?format=record§ion=agents - `alpha://company/60-degrees-pharmaceuticals-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/60-degrees-pharmaceuticals-inc?format=record§ion=ecosystem - `alpha://company/60-degrees-pharmaceuticals-inc/events` (contract): https://registry.alpha.ac/api/public/companies/60-degrees-pharmaceuticals-inc?format=record§ion=events - `alpha://company/60-degrees-pharmaceuticals-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/60-degrees-pharmaceuticals-inc?format=record§ion=relationships - `alpha://company/60-degrees-pharmaceuticals-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/60-degrees-pharmaceuticals-inc?format=record§ion=assessments - `alpha://company/60-degrees-pharmaceuticals-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/60-degrees-pharmaceuticals-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:committee_appointment:14: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:charles-allen","name":"Charles Allen"},"source_id":"board_seats"}` - Claim alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:committee_appointment:15: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:paul-field","name":"Paul Field"},"source_id":"board_seats"}` - Claim alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:committee_appointment:16: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:stephen-toovey","name":"Stephen Toovey"},"source_id":"board_seats"}` - Claim alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:paul-field","name":"Paul Field"},"source_id":"board_seats"}` - Claim alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:charles-allen","name":"Charles Allen"},"source_id":"board_seats"}` - Claim alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:stephen-toovey","name":"Stephen Toovey"},"source_id":"board_seats"}` - Claim alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:stephen-toovey","name":"Stephen Toovey"},"source_id":"board_seats"}` - Claim alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:charles-allen","name":"Charles Allen"},"source_id":"board_seats"}` - Claim alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:paul-field","name":"Paul Field"},"source_id":"board_seats"}` ## Leadership - Charles Allen: Director, Audit · Chair; Compensation; Nominating and Governance. Claim: alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:5. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0f247b1344d6a30c1ede322f04dbc49c618fb15dc9b24a786685646f8e3673eb. - Cheryl Xu: Director. Claim: alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:6. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0f247b1344d6a30c1ede322f04dbc49c618fb15dc9b24a786685646f8e3673eb. - Geoffrey Dow: Director. Claim: alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:7. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0f247b1344d6a30c1ede322f04dbc49c618fb15dc9b24a786685646f8e3673eb. - Paul Field: Director, Audit; Compensation · Chair; Nominating and Governance. Claim: alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:8. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0f247b1344d6a30c1ede322f04dbc49c618fb15dc9b24a786685646f8e3673eb. - Stephen Toovey: Director, Audit; Compensation; Nominating and Governance · Chair. Claim: alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:9. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0f247b1344d6a30c1ede322f04dbc49c618fb15dc9b24a786685646f8e3673eb. - Geoffrey Dow: Chief Executive Officer, President and Director. Claim: alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:10. Valid from: 2026-03-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:25171feed72af2e5884b09cd999f0e5673e02ed232d641d7916b4b7c67398e96. - Kristen Landon: Chief Commercial Officer. Claim: alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:11. Valid from: 2026-03-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5d255c60bd5e0af0200184ec52ad12de461b7fe554eb86e8b0aaceee8aba7533. - Theodore C. Miller: Chief Financial Officer. Claim: alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:12. Valid from: 2026-03-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f7c265fa61202abeb00e450e7dfc0c757e7ae8132f8b11ad023eb8e3ea370698. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Charles Allen; Members Charles Allen (Chair); Paul Field; Stephen Toovey. Claim: alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:committee_record:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:803f6922af694833a697871ee8bdca0a7e9c8bb9fe7f7dd45adaa4d733fe1b60. - Compensation: Chair Paul Field; Members Paul Field (Chair); Charles Allen; Stephen Toovey. Claim: alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:committee_record:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:803f6922af694833a697871ee8bdca0a7e9c8bb9fe7f7dd45adaa4d733fe1b60. - Nominating and Governance: Chair Stephen Toovey; Members Stephen Toovey (Chair); Charles Allen; Paul Field. Claim: alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:committee_record:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:803f6922af694833a697871ee8bdca0a7e9c8bb9fe7f7dd45adaa4d733fe1b60. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - 60 DEGREES PHARMACEUTICALS, INC.. Claim: alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:78c0c8f7c088ab1433d08cf5fa157cdd5e2d990104f9bf218cbe65b755a429ea. ## Entity Status - Public listing published. Claim: alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:78c0c8f7c088ab1433d08cf5fa157cdd5e2d990104f9bf218cbe65b755a429ea. ## Published Fact - US. Claim: alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:78c0c8f7c088ab1433d08cf5fa157cdd5e2d990104f9bf218cbe65b755a429ea. ## Committee Appointment - Charles Allen: chair, Audit. Claim: alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:committee_appointment:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:803f6922af694833a697871ee8bdca0a7e9c8bb9fe7f7dd45adaa4d733fe1b60. - Paul Field: member, Audit. Claim: alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:committee_appointment:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:803f6922af694833a697871ee8bdca0a7e9c8bb9fe7f7dd45adaa4d733fe1b60. - Stephen Toovey: member, Audit. Claim: alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:committee_appointment:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:803f6922af694833a697871ee8bdca0a7e9c8bb9fe7f7dd45adaa4d733fe1b60. - Paul Field: chair, Compensation. Claim: alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:803f6922af694833a697871ee8bdca0a7e9c8bb9fe7f7dd45adaa4d733fe1b60. - Charles Allen: member, Compensation. Claim: alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:803f6922af694833a697871ee8bdca0a7e9c8bb9fe7f7dd45adaa4d733fe1b60. - Stephen Toovey: member, Compensation. Claim: alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:803f6922af694833a697871ee8bdca0a7e9c8bb9fe7f7dd45adaa4d733fe1b60. - Stephen Toovey: chair, Nominating and Governance. Claim: alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:803f6922af694833a697871ee8bdca0a7e9c8bb9fe7f7dd45adaa4d733fe1b60. - Charles Allen: member, Nominating and Governance. Claim: alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:803f6922af694833a697871ee8bdca0a7e9c8bb9fe7f7dd45adaa4d733fe1b60. - Paul Field: member, Nominating and Governance. Claim: alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:803f6922af694833a697871ee8bdca0a7e9c8bb9fe7f7dd45adaa4d733fe1b60. ## Security Listing - SXTP (NASDAQ). Claim: alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:security_listing:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:78c0c8f7c088ab1433d08cf5fa157cdd5e2d990104f9bf218cbe65b755a429ea. - SXTPW (NASDAQ). Claim: alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:security_listing:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:78c0c8f7c088ab1433d08cf5fa157cdd5e2d990104f9bf218cbe65b755a429ea. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:78c0c8f7c088ab1433d08cf5fa157cdd5e2d990104f9bf218cbe65b755a429ea: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/60-degrees-pharmaceuticals-inc). - alpha:projection-evidence:document:0f247b1344d6a30c1ede322f04dbc49c618fb15dc9b24a786685646f8e3673eb: [60 DEGREES PHARMACEUTICALS, INC. DEF 14A 2025-08-27](https://www.sec.gov/Archives/edgar/data/1946563/000121390025080878/ea0254708-def14a_60degrees.htm). - alpha:projection-evidence:document:25171feed72af2e5884b09cd999f0e5673e02ed232d641d7916b4b7c67398e96: [SXTP 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1946563/000155485526000467/sxtp-20251231.htm). - alpha:projection-evidence:document:5d255c60bd5e0af0200184ec52ad12de461b7fe554eb86e8b0aaceee8aba7533: [SXTP 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1946563/000155485526000467/sxtp-20251231.htm). - alpha:projection-evidence:document:f7c265fa61202abeb00e450e7dfc0c757e7ae8132f8b11ad023eb8e3ea370698: [SXTP 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1946563/000155485526000467/sxtp-20251231.htm). - alpha:projection-evidence:803f6922af694833a697871ee8bdca0a7e9c8bb9fe7f7dd45adaa4d733fe1b60: [Audit](https://www.sec.gov/Archives/edgar/data/1946563/000121390025080878/ea0254708-def14a_60degrees.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/60-degrees-pharmaceuticals-inc) - [Public Markdown](https://registry.alpha.ac/companies/60-degrees-pharmaceuticals-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/60-degrees-pharmaceuticals-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/60-degrees-pharmaceuticals-inc?format=jsonld) - MCP resource: `alpha://companies/60-degrees-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-16T01:55:06.795015+00:00; recorded 2026-10-16T01:55:06.795015+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.